News

The acquisition was announced on May 27 th with a price of $25 per share, which represents a 34.6% premium over the 30-day ...
But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt. So should Immuneering (NASDAQ:IMRX) shareholders be worried about its cash burn? For the ...
Given this risk, we thought we'd take a look at whether Kalaris Therapeutics (NASDAQ:KLRS) shareholders should be worried about its cash burn. In this report, we will consider the company's annual ...
U.S. stock futures pointed to a slightly weaker open when trading resumes, even after President Trump's delay to a decision on U.S. involvement in the Israel-Iran conflict improved risk sentiment a ...
Salesforce drives growth with AI-powered Agentforce, expanding margins and CRM leadership. Read more on CRM stock and its buy ...